Accenture recently released survey shows that in the United States, 51 percent of digital medical start-ups fail within the first two years. According to labor statistics department data, between 1994-2009, the overall failure rate of start-up companies in the same period probably between 20% to 26%. Visible digital medical business failure rate is much higher than the overall.

How to understand two aspects to this case. First, the success of the project because of what the weather, geography, and successful. Second, these failed projects so ignore what factors lead to failure.

First look behind bigger models has what kind of motivating factor. There is a class because of policy changes resulting from rapid growth, such as telemedicine Teladoc. This mode can be fast big reason is because health care reform has brought community willingness to pay, employers can benefit from telemedicine services - saving medical costs.

For commercial insurers, telemedicine lower prices for their services cost control is also very attractive. These favorable conditions due to the emergence of health care reform, because Obama's health reform policy clearly based on efficacy and medical value to paid model, to hospitals and payers greater pressure to control the quality of service and cost.

Another is based on the B-side customers for the sale of the object model, able to prove its worth in the industry for institutional clients, and last acquisitions of large companies in the industry. For example, Merck acquired the company last year, remote ECG monitoring eCardio, the company offers professional remote heart monitor, and a set of efficient algorithms to detect arrhythmias.

Doctors can use this product for up to 30 days of ECG monitoring. These products plus services have been deep into the hospital and get a doctor's approval, can effectively help Merck to seize B-side customers, enhance compliance, and then to produce a synergistic own business.

Such figures have obvious medical professional project threshold, its path is B2B, but eventually you can really get professional C-side data, and the acquirer's core business through the B linkage. Directed against the C-terminus of digital medical model, this model can bring the B2B2C market compared to the C-terminus batch effective information and data, and these data to the bodies has a direct value. This is the nature of the mass and for the pattern is completely different from the C-terminus.